The Spanish Heart Transplant Registry presents the results of the activity corresponding to 2024, analyzing trends in recipient and donor profiles, the use of mechanical circulatory support, and survival patterns over the past decade.
This multicenter retrospective study analyzes long-term survival benchmarks among patients with preserved left ventricular ejection fraction (LVEF) and three-vessel coronary artery disease (CAD) who underwent isolated surgical revascularization, comparing their survival with an age- and sex-matched cohort from the general U.S. population.
This update article, released by the American Heart Association (AHA), summarizes the main indications for intraoperative transesophageal echocardiography (TEE), its association with clinical outcomes and prognostic value, and provides a hierarchy of specific considerations for different types of cardiac surgery.
A recent study compared outcomes of transcatheter edge-to-edge repair (Abbott MitraClip®) versus surgical mitral repair in octogenarian patients with severe organic mitral regurgitation, aiming to evaluate safety, efficacy, and midterm outcomes
Retrospective analysis of 46 patients who underwent transcarotid TAVI at a single Swiss center, focusing on two quantifiable parameters derived from preoperative CT angiography.
A randomized US trial aimed to determine whether concomitant tricuspid valve surgery (TVS) at the time of durable left ventricular assist device (LVAD) implantation reduces tricuspid regurgitation (TR) and the incidence of long-term right heart failure (RHF).
A new U.S. study analyzes outcomes of transcatheter aortic valve implantation (TAVI) versus conventional surgical aortic valve replacement (SAVR) in patients younger than 65 years, highlighting the growing expansion of TAVI despite limited evidence on long-term durability.
This study analyzes data from the ACTION registry to assess whether morbidity and mortality after ventricular assist device (VAD) implantation differ between children with and without congenital heart disease (CHD), and whether outcomes among those with CHD vary according to anatomy (single- vs. biventricular).
The 2025 ESC/EACTS update redefines the boundaries between surgery and transcatheter therapy. It advocates earlier intervention in severe aortic stenosis, lowers the age threshold for TAVI to 70 years, expands the use of MitraClip to lower-risk scenarios, promotes percutaneous tricuspid treatment, and grants a new central role to advanced imaging in decision-making.
This national study compares the efficiency of robotic-assisted versus conventional mitral valve repair in the United States, stratifying centers by surgical volume and experience.
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.